A monthly recap of the latest news about Alzheimer’s and dementia
On April 30, the FDA granted approval for a combination medication of dextromethorphan and bupropion for the treatment of agitation in Alzheimer’s disease. Read more.
A new approach to dementia care
A year after launching an ambitious research effort to support dementia patients and caregivers, UC Irvine nursing researchers have moved into real-world care settings, collecting data directly from patients and using AI-driven technology to better understand agitation, sleep disruption and fall risk. Read more.
Eating eggs may be linked to lower Alzheimer’s risk
A new study found that older Americans who included eggs in their diets reduced their risk of Alzheimer’s disease compared to their peers who rarely or never ate eggs. Read more.
Sex differences in dementia risks reveal stronger cognitive impacts in women
Researchers from the University of California San Diego School of Medicine found that women not only experience a higher burden of certain modifiable dementia risk factors, but also appear more vulnerable to their effects on cognitive function. Read more.
Severe bacterial infections linked to higher dementia risk
People are hospitalized with severe infections — such as COVID-19, pneumonia, or other diseases — are more likely to develop dementia years later. Read more.
Can gene therapy change the course of Alzheimer’s?
After breakthroughs in blindness and rare neurological diseases, researchers are testing whether gene therapy can slow or prevent Alzheimer’s. Read more.
